Credits: Canva
Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.
The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.
The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.
The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.
The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.
Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."
The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.
However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.
Credit: iStock
The US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have traced an ongoing Cyclospora outbreak in at least five states to shredded iceberg lettuce supplied to select Taco Bell restaurants.
The agencies have advised consumers: "Do not eat shredded iceberg lettuce from Taco Bell locations in Indiana, Kentucky, Michigan, Ohio, and West Virginia."
The FDA identified Taylor Farms as the supplier of the shredded iceberg lettuce served at the affected Taco Bell locations, where it is linked to illnesses in more than 1,644 people.
Taylor Farms is one of the world's largest producers of fresh salads and ready-to-eat foods, with production facilities across the US, Canada, Mexico, and Western Europe.
The FDA is working with the company to determine whether the contaminated lettuce was distributed to other businesses. Taco Bell has voluntarily removed the affected ingredients from the impacted restaurants.
The Cyclospora outbreak has been reported in more than 30 states. The CDC said this investigation is separate from other Cyclospora outbreaks currently being monitored nationwide.
Michigan has reported the highest number of cases, with state officials identifying leafy lettuce as the leading suspected source after interviewing more than 1,000 patients.
As of July 16, the state had reported more than 4,300 cases and at least 100 hospitalizations linked to the outbreak.
According to the CDC, 1,645 confirmed US cases have been reported since May 1, while more than 5,100 cases are under review to determine whether the infections were acquired domestically.
No deaths have been reported, although officials warned that confirmed case numbers could continue to increase through the end of August.
Earlier this week, Taco Bell said it has voluntarily and temporarily removed limited fresh ingredients from select restaurants as a precaution.
Notices posted at some Detroit-area Taco Bell restaurants last week informed customers that the chain was temporarily unable to serve lettuce, cilantro, onions, pico de gallo, and guacamole due to a nationwide recall, according to media reports.
The company said it will continue to monitor the situation and follow guidance from public health authorities.
"The health and safety of our guests is our top priority," Taco Bell said in a statement.
Health officials recommend:
Experts also recommend choosing whole heads of lettuce instead of bagged greens. Remove the outer leaves, wash the inner leaves thoroughly under running water, and cook produce whenever possible, as heat is the most effective way to kill Cyclospora.
Cyclospora cayetanensis is a microscopic parasite that causes cyclosporiasis, a foodborne intestinal illness. People become infected after consuming contaminated food or water.
Symptoms usually begin about one week after exposure, although they can appear anywhere from two days to more than two weeks later. Common symptoms include:
The CDC also advises people with persistent diarrheal illness to specifically request testing for Cyclospora, as routine stool tests do not always screen for the parasite.
Credit: iStock
The highly pathogenic avian influenza (H5N1) virus has been detected in New Zealand for the first time, raising concerns for the country's native birds.
NZ health authorities confirmed the virus in a wild seabird while stressing that there is currently no evidence of wider transmission within the country.
The infected bird, a brown skua, was found on Petone Beach in Wellington on July 10 and tested positive for H5N1. The detection comes just weeks after the virus was confirmed in Australia, a development that had prompted New Zealand authorities to prepare for its possible arrival. the country now confirming 14 infections.now confirming 14 infections.
New Zealand Biosecurity Minister Andrew Hoggard said the case appears to be isolated.
"There is no evidence of any mass mortality in wildlife or transmission between wild birds in New Zealand," Hoggard said, while urging the public to remain vigilant and report sick or dead birds.
Health and wildlife officials have launched enhanced surveillance to determine whether additional infections emerge in wild bird populations.
Also read: Australia’s H5N1 Detection Marks End Of Last Virus-Free Continent
The latest H5N1 detection comes as the US Centers for Disease Control and Prevention (CDC), in June, reported identifying 12 human H5N1 infections outside the US between August 4, 2025, and June 10, 2026.
According to the CDC, the cases were reported in:
Importantly, the CDC said no person-to-person transmission was identified in any of these cases. Most infections occurred after direct or close contact with infected poultry or other sick animals.
The agency said the international cases do not change its assessment that the risk of H5N1 to the general public remains low, but they reinforce the need for continued monitoring.
Cambodia's Ministry of Health on July 9 confirmed the fifth H5N1 human infection of 2026, in a 9-month-old girl from Phnom Penh. It is the 39th case in the country in the last three years.
The CDC noted that sporadic human infections are expected as H5N1 continues circulating widely among wild birds and poultry across multiple regions.
"While rare, these H5N1 bird flu cases in humans underscore the need for strong systems to monitor and prepare for influenza," the agency said, calling for robust surveillance and testing.
Read More: Cyclosporiasis Outbreak: US Probes Taco Bell Link; CDC Reviews Over 5,100 Cases
Scientists have identified five avian influenza virus subtypes capable of infecting humans:
Although the overall risk to the public remains low, health experts called for continued surveillance in birds, animals, and humans, which will be essential as H5N1 continues to spread geographically.
Health authorities recommend the following precautions:
Credit: iStock
Amid reports of rare botulism cases in the UK, the country's Medicines and Healthcare products Regulatory Agency (MHRA) has issued a safety warning for all botulinum toxin type A products, including Botox and other cosmetic injectables.
The regulator said cases of iatrogenic botulism—botulism caused by medical treatment—have been reported following both therapeutic and cosmetic use of botulinum toxin products when the toxin spreads beyond the intended injection site.
"Patients should seek immediate medical advice if they experience signs and symptoms," the MHRA said.
Botulinum toxin medicines are widely used for cosmetic procedures, such as reducing facial wrinkles, as well as for treating conditions including muscle spasms, excessive sweating (hyperhidrosis), and an overactive bladder.
While these medicines are considered safe when used correctly, the MHRA warned that, in very rare cases, the toxin can spread beyond the injection site and cause botulism—a serious and potentially life-threatening condition.
To improve awareness, the regulator has worked with manufacturers to update product information and patient leaflets to more clearly highlight the risk of iatrogenic botulism.
Also read: GLP-1 Weight-Loss Drugs Show Promise for 17 Million With Binge Eating Disorder, Suggests Study
The MHRA warned that symptoms may not appear immediately after treatment. They can develop within days or even up to four weeks after receiving a botulinum toxin injection.
Patients are advised to seek immediate medical attention if they experience:
According to the MHRA, the risk of serious side effects may be higher in:
Health officials say early recognition of symptoms is critical, as prompt treatment can help prevent serious complications.
"While botulism is a rare infection, it can be serious. There are effective treatments available, and we recommend seeking immediate medical advice if you have had a recent treatment and are experiencing symptoms such as difficulty swallowing," said Dr. Martin Bewley, Consultant in Health Protection at the UK Health Security Agency (UKHSA).
Dr. Alison Cave, Chief Safety Officer at the MHRA, recommended that healthcare professionals and patients be aware of the symptoms of botulism and act quickly if they arise. Importantly, the expert "strongly urged the public to avoid unlicensed products and seek treatment only from appropriately qualified practitioners."
Botulism is a rare but serious illness caused by a toxin produced by the bacterium Clostridium botulinum. The toxin attacks the nervous system and can lead to paralysis, breathing difficulties, and, in severe cases, death if not treated promptly.
Because it can rapidly affect the muscles involved in breathing, botulism is considered a medical emergency.
© 2024 Bennett, Coleman & Company Limited